Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
第一作者:
Andrew,Whelton
第一单位:
Universal Clinical Research Center, Inc., and The Johns Hopkins University School of Medicine, Baltimore, Maryland 21030-1603, USA. huntvalley@col.com
作者:
主题词
年龄因素(Age Factors);老年人(Aged);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);抗高血压药(Antihypertensive Agents);血压(Blood Pressure);环加氧酶抑制药(Cyclooxygenase Inhibitors);双盲法(Double-Blind Method);药物评价(Drug Evaluation);水肿(Edema);女(雌)性(Female);心力衰竭(Heart Failure);人类(Humans);高血压(Hypertension);内酯类(Lactones);男(雄)性(Male);北美洲(North America);骨关节炎(Osteoarthritis);吡唑类(Pyrazoles);磺胺类(Sulfonamides);砜类(Sulfones);心缩期(Systole);治疗结果(Treatment Outcome);体重增长(Weight Gain)
DOI
10.1016/s0002-9149(02)02661-9
PMID
12398962
发布时间
2022-03-10
- 浏览24
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文